Generative AI in Healthcare Market Size & Share 2024 – 2032

Generative AI in Healthcare Market Size

The global generative AI in healthcare market was valued at USD 1.8 billion in 2023 and is expected to exhibit growth at a CAGR of 33.2% from 2024 to 2032. High market growth can be attributed to the advancements in deep learning and natural language processing (NLP), increasing demand for personalized treatment, growing investment in healthcare AI, and rising healthcare data volumes, among other contributing factors.

Moreover, the rapid advancement of deep learning models, including GPT and NLP tools, enables various healthcare applications. These include medical imaging analysis, automated reporting, and conversational AI for patient assistance. Such technological progress is driving the adoption of generative AI solutions in the healthcare sector.
 

Furthermore, governments, private organizations, and venture capitalists have been making significant investments in generative AI technologies to enhance healthcare efficiency. For instance, the U.S. government, through the National Institutes of Health (NIH), allocated USD 1.5 billion to AI research in healthcare between 2018 and 2022. This substantial funding has accelerated advancements in AI-driven drug discovery and medical diagnostics, fostering innovation and driving market expansion.
 

Generative AI in healthcare refers to the application of artificial intelligence (AI) techniques that involve the generation of new and original data. Also, in the healthcare sector, generative AI is used for tasks such as generating synthetic medical images, creating virtual patient data for training healthcare algorithms, simulating disease progression, and even designing novel molecules for drug discovery.
 

Generative AI in Healthcare Market Trends

The market is experiencing several market trends that are shaping its growth and development. Factors such as advancements in artificial intelligence, increasing investment, and a focus on improving healthcare efficiency and outcomes, among other factors are boosting the industry growth.
 

• Generative AI is increasingly being applied to personalize treatment plans by analyzing vast datasets of patient information, including genetic, clinical, and lifestyle data. This trend is particularly impactful in fields like oncology and rare disease treatment, where tailored therapeutic strategies are critical.
   
• Additionally, generative AI is accelerating the drug discovery process by predicting molecular structures, identifying potential drug candidates, and optimizing drug designs. This has significantly reduced the time and cost associated with traditional pharmaceutical research, making it a dominant trend in the healthcare market, thereby aforementioned factors are expected to drive the market.
   

Generative AI in Healthcare Market Analysis

Based on application, the market is classified into medical image analysis and diagnostics, drug discovery and development, patient assistance and monitoring, personalized treatment and other applications. The medical image analysis and diagnostics segment generated the highest revenue of USD 655.4 million in 2023.
 

• The increasing global prevalence of chronic diseases is driving the demand for advanced diagnostic tools. For example, according to the World Heart Federation, cardiovascular diseases affect over 500 million individuals worldwide, causing 20.5 million deaths in 2021. Similarly, the American Cancer Society estimates that around 1.9 million new cancer cases were diagnosed in the U.S. in 2023. As a result, AI in medical imaging has become essential for the early detection and monitoring of these diseases, significantly contributing to market growth.
   
• Moreover, early detection is key to improving patient outcomes, and AI models assist in identifying potential health issues before they become symptomatic. By providing more detailed and quicker diagnoses, generative AI helps healthcare providers detect diseases in the early stages, which is essential for preventive healthcare.
   

Based on end use, the generative AI in healthcare market is segmented into healthcare providers, pharmaceutical and life sciences companies, and healthcare payors. The healthcare providers segment is further divided into hospitals and clinics, diagnostic centers, and other healthcare providers. The healthcare providers segment dominated the market in 2023 and is anticipated to reach USD 9.7 billion by the end of forecast period.
 

• Generative AI can automate various administrative and clinical tasks, such as patient record management, appointment scheduling, and insurance claim processing. This reduces administrative burdens, streamlines workflows, and improves overall operational efficiency, allowing healthcare providers to focus more on patient care.
   
• Moreover, healthcare providers face increasing pressure to reduce costs while maintaining high-quality care. Generative AI can contribute to cost reduction by automating routine tasks, reducing the need for additional tests, and minimizing human errors. For example, a study published in the Journal of the American Medical Association found that AI-assisted diagnosis could reduce unnecessary medical tests by up to 25%. Therefore, AI can optimize resource allocation and lower hospital readmission rates, leading to long-term cost savings. These factors are expected to further facilitate market growth in the generative AI in healthcare segment.
   

North America generative AI in healthcare market accounted for USD 758.7 million market revenue in 2023 and is anticipated to grow at a CAGR of 33.3% between 2024 to 2032 period.
 

• North America, particularly the U.S. and Canada, boasts one of the most advanced healthcare infrastructures globally. This includes cutting-edge medical facilities, research institutions, and a robust network of hospitals and clinics that are adopting generative AI technologies to enhance patient care, streamline operations, and optimize resource management. The strong healthcare infrastructure supports the integration of AI tools and technologies into everyday medical practice.
   
• Further, the region is at the forefront of technological readiness and digital transformation within healthcare. The rapid adoption of electronic health records (EHR), telemedicine, and health IT infrastructure creates an ideal environment for integrating generative AI into healthcare workflows. This digitized landscape facilitates the use of AI tools for clinical decision support, data analysis, and patient engagement. Thus, the aforementioned factors are anticipated to propel market growth during the forecast period.
   

Germany generative AI in healthcare market is projected to grow remarkably in the coming years.
 

• Germany's government actively promotes AI innovation through initiatives like the AI Made in Germany strategy, which includes funding and support for AI research and applications in healthcare. This policy framework encourages the development and deployment of generative AI in medical and healthcare settings.
   
• Moreover, the country is home to a strong pharmaceutical and biotechnology sector, which is increasingly using generative AI for drug discovery, molecular design, and clinical trial optimization. The technology helps accelerate the drug development process, a significant driver in the market.
   

China holds a dominant position in the Asia Pacific generative AI in healthcare market.
 

• China’s vast and diverse population creates a massive demand for scalable and efficient healthcare solutions. Generative AI plays a key role in addressing these needs by providing personalized diagnostics, treatments, and virtual care options to manage the high patient volume.
   
• The country's robust startup ecosystem is actively developing AI-driven healthcare solutions, including generative AI tools. High levels of venture capital and government funding have propelled innovations in areas like medical imaging, drug discovery, and virtual health assistants.
   

Generative AI in Healthcare Market Share

The market features a dynamic competitive landscape driven by major technology firms, healthcare-focused AI startups, and partnerships between industry leaders. Companies like Google LLC, NVIDIA Corporation, Microsoft, and IBM Corporation leverage their advanced AI capabilities to create innovative solutions for medical imaging, diagnostics, and patient engagement. Meanwhile, specialized players such as Abridge, PathAI, and Insilico Medicine offer niche generative AI tools tailored to healthcare applications like clinical documentation, pathology, and drug discovery. Collaboration between tech giants and healthcare providers further accelerates market growth, fostering innovation and increasing accessibility to AI-powered healthcare solutions.
 

Generative AI in Healthcare Market Companies

Prominent players operating in the generative AI in healthcare industry include:

• Abridge Al
• DiagnaMed Holdings
• ELEKS
• Google LLC (Alphabet)
• Insilico Medicine
• International Business Machines
• Microsoft
• NVIDIA
• Oracle
• Persistent Systems
• Syntegra
   

Generative AI in Healthcare Industry News:

• In October 2024, Google Cloud and Citi formed a strategic partnership to modernize Citi's infrastructure with cloud and AI technologies, using Vertex AI for generative AI capabilities. This collaboration expands Google Cloud's presence in the financial sector, strengthens its AI leadership, and boosts adoption of its services, driving business growth and market penetration.
   
• In September 2024, Insilico Medicine announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next generation immunotherapeutic. It enhances Insilico’s reputation as a leader in generative AI-driven drug development while expanding its reach into the immunotherapy market.
   

The generative AI in healthcare market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2023 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Application

• Medical image analysis and diagnostics
• Drug discovery and development
• Patient assistance and monitoring
• Personalized treatment
• Other applications

Market, By End Use

• Healthcare providers
  • Hospitals and clinics
  • Diagnostic centers
  • Other healthcare providers
• Pharmaceutical and life sciences companies
• Healthcare payors

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa
  • Saudi Arabia